Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
PTC Therapeutics (PTCT)
NASDAQ:PTCT
PTC Therapeutics (PTCT) Stock Price & Analysis
279 Followers
PTCT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$23.57 - $59.84
Previous Close$24.82
Volume1.51M
Average Volume (3M)831.97K
Market Cap
$1.87B
Enterprise ValueN/A
Total Cash (Recent Filing)$337.94M
Total Debt (Recent Filing)$702.68M
Price to Earnings (P/E)-2.9
Beta1.00
Next Earnings
Oct 26, 2023EPS Estimate
-$1.17Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-8.42
Shares Outstanding75,344,951
10 Day Avg. Volume2,117,888
30 Day Avg. Volume831,971
Standard Deviation0.12
R-Squared0.03
Alpha0.00337
Financial Highlights & Ratios
Price to Book (P/B)-1.64
Price to Sales (P/S)10.71
Price to Cash Flow (P/CF)4.00
P/FCF Ratio4.80
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price Target
$38.42Price Target Upside60.62% Upside
Rating ConsensusHold
Number of Analyst Covering14
PTC Therapeutics News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
PTCT FAQ
What was PTC Therapeutics’s price range in the past 12 months?
PTC Therapeutics lowest stock price was $23.57 and its highest was $59.84 in the past 12 months.
What is PTC Therapeutics’s market cap?
Currently, no data Available
When is PTC Therapeutics’s upcoming earnings report date?
PTC Therapeutics’s upcoming earnings report date is Oct 26, 2023 which is in 33 days.
How were PTC Therapeutics’s earnings last quarter?
PTC Therapeutics released its earnings results on Aug 03, 2023. The company reported -$2.66 earnings per share for the quarter, missing the consensus estimate of -$1.621 by -$1.039.
Is PTC Therapeutics overvalued?
According to Wall Street analysts PTC Therapeutics’s price is currently Undervalued.
Does PTC Therapeutics pay dividends?
PTC Therapeutics does not currently pay dividends.
What is PTC Therapeutics’s EPS estimate?
PTC Therapeutics’s EPS estimate is -$1.17.
How many shares outstanding does PTC Therapeutics have?
PTC Therapeutics has 75,344,950 shares outstanding.
What happened to PTC Therapeutics’s price movement after its last earnings report?
PTC Therapeutics reported an EPS of -$2.66 in its last earnings report, missing expectations of -$1.621. Following the earnings report the stock price went down -3.993%.
Which hedge fund is a major shareholder of PTC Therapeutics?
Among the largest hedge funds holding PTC Therapeutics’s share is Blackstone Inc.. It holds PTC Therapeutics’s shares valued at 45M.
---
PTC Therapeutics Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$38.42 (60.62% Upside)
$38.42 (60.62% Upside)
Blogger Sentiment
Bullish
PTCT Sentiment 100%
Sector Average 67%
Sector Average 67%
Hedge Fund Trend
Decreased
By 430.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $465.0K over
the Last 3 Months
the Last 3 Months
News Sentiment
Negative
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-50.74%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-25.83%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
PTC Therapeutics
PTC Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and commercialization of clinically-differentiated medicines. It focuses on the development of new treatments for multiple therapeutic areas, including rare diseases and oncology. The company was founded by Allan Steven Jacobson and Stuart W. Peltz on March 31, 1998 and is headquartered in South Plainfield, NJ.
---
Top 5 ETFs holding PTCT
Vanguard Total Stock Market ETF
$91.46M
Vanguard Health Care ETF
$9.14M
Schwab U.S. Broad Market ETF
$984.96K
Fidelity Nasdaq Composite Index ETF
$728.50K
Vanguard Russell 3000 ETF
$176.80K
Up to five ETFs with an Outperform Smart Score that hold PTCT. The ETFs are listed according to market value of PTCT within the ETF
---